Inpharma Weekly

, Volume 1322, Issue 1, pp 12–12 | Cite as

Distinct molecular parameters predict survival in chemotherapy

Clinical study


Irinotecan Oxaliplatin Metastatic Colon Cancer Median Survival Duration Prolonged Median Survival 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2002

Personalised recommendations